glp-1 food demand news Impact of Weight Loss Drugs on Choices GLP‑1 food trends: What manufacturers

Type 2 diabetes mellitus: a comprehensive review of pathophysiology, comorbidities, and emerging therapies

Leveraging the natural effects of GLP-1, these agonists encourage weight loss through various pathways, including enhancing satiety and promoting better glycemic control

Real patients, real results

While pharmacotherapies targeting the GLP-1 system have been widely successful for the treatment of type 2 diabetes (T2D) and obesity, the use of GIP analogs as monotherapies has been largely underwhelming in preclinical and clinical studies and even produced some controversial findings (review in 19,20)

Drug approvals and databases

Benedikt Linz, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen N, Denmark